Arlington Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-623
Closed -$33K 487
2022
Q1
$33K Hold
623
0.01% 279
2021
Q4
$38K Hold
623
0.01% 305
2021
Q3
$35K Hold
623
0.01% 299
2021
Q2
$32K Sell
623
-829
-57% -$39.8K 0.01% 223
2021
Q1
$64K Buy
+1,452
New +$61K 0.02% 207

Other funds holding PBH

Arlington Partners's PBH Position: Q2 2022 in Review

Arlington Partners sold out of Prestige Consumer Healthcare (PBH) in Q2 2022, closing a stake of 623 shares — an estimated $33K sold.

Arlington Partners first reported a position in PBH in Q1 2021 and held it in 5 quarters. The position peaked at $64K in Q1 2021. 285 funds tracked by Wall St. Rank hold PBH as of Q2 2022.

  • Arlington Partners reported no remaining Prestige Consumer Healthcare position as of Q2 2022 after selling out during the quarter.
  • Arlington Partners sold 623 Prestige Consumer Healthcare shares in Q2 2022, an estimated $33K.
  • Arlington Partners first reported a position in Prestige Consumer Healthcare in Q1 2021 and held it in 5 quarters.
  • Arlington Partners's Prestige Consumer Healthcare position peaked at $64K in Q1 2021.
  • 285 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2022.

Based on Arlington Partners's 13F filing for Q2 2022, filed 25 Jul 2022.